Beijing Tiantan Biological Products Dividend
Dividend criteria checks 2/6
Beijing Tiantan Biological Products is a dividend paying company with a current yield of 0.51% that is well covered by earnings.
Key information
0.5%
Dividend yield
21%
Payout ratio
Industry average yield | 1.3% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.125 |
Earnings per share | CN¥0.59 |
Dividend yield forecast in 3Y | 0.6% |
Recent dividend updates
No updates
Recent updates
Does Beijing Tiantan Biological Products (SHSE:600161) Deserve A Spot On Your Watchlist?
Jul 23Is Beijing Tiantan Biological Products Co., Ltd. (SHSE:600161) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 09Beijing Tiantan Biological Products Co., Ltd.'s (SHSE:600161) Price Is Out Of Tune With Earnings
May 22We Think Beijing Tiantan Biological Products (SHSE:600161) Can Stay On Top Of Its Debt
Mar 16Do Beijing Tiantan Biological Products' (SHSE:600161) Earnings Warrant Your Attention?
Mar 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 600161 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 600161's dividend payments have increased, but the company has only paid a dividend for 7 years.
Dividend Yield vs Market
Beijing Tiantan Biological Products Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (600161) | 0.5% |
Market Bottom 25% (CN) | 0.7% |
Market Top 25% (CN) | 2.6% |
Industry Average (Biotechs) | 1.3% |
Analyst forecast in 3 Years (600161) | 0.6% |
Notable Dividend: 600161's dividend (0.51%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.73%).
High Dividend: 600161's dividend (0.51%) is low compared to the top 25% of dividend payers in the CN market (2.65%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (21.4%), 600161's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (22.7%), 600161's dividend payments are well covered by cash flows.